Stem Cell Blog

Употребата на матичните клетки од папочна врвца рапидно се зголемува. Пред 10 години крвта од папочна врвца можеше да лекува околу 40 состојби, но денес таа бројка е над 80. Со нетрпение очекуваме нови терапии за болести и нарушувања како што се дијабет, аутизам и мозочен удар, можете да бидете во тек со најновите случувања во регенеративната медицина на нашиот блог за матични клетки.



Michael-Schumacher-Blog.png

The seven-time World Champion driver, Michael Schumacher, is set to undergo stem cell therapy in an attempt to regenerate his nervous system.

Back in 2013, Schumacher suffered a severe brain injury in a skiing accident. Since sustaining the severe life altering injury over 6 and a half years ago, the Formula 1 icon’s physical condition has been closely guarded by his family and those around him.


Stem-cell-mist-UAE-blog.png

Researchers in Abu Dhabi have developed a ground breaking stem cell treatment for COVID-19 patients with initial data showing promising results.

Stem cells can currently treat a wide array of conditions, from immune disorder to blood cancers – and this list keeps on growing. In an exciting new breakthrough, stem cells have proven to be a successful treatment for patients suffering from coronavirus.



A team of scientists in Japan have demonstrated that neurons derived from stem cells can be used to treat the symptoms of Parkinson’s in monkeys.

Parkinson’s affects around 1 in 500 people in the UK and is caused when dopamine-producing nerve cells degenerate and can no longer work effectively. Dopamine is responsible for sending signals to the part of the brain that controls movement; lack of dopamine is responsible for the jerky and uncontrolled movements symptomatic of Parkinson’s.


autism-clinical-trial-blog.png

A new phase II clinical trial has indicated that umbilical cord blood infusions are safe and are associated with improved social and communication abilities in children with autism.

Results from the study show that umbilical cord blood infusion were safe and well tolerated by the 180 children participating in the clinical trial. Cord blood was also associated with improvements in communication skills in children with autism spectrum disorder (ASD) without intellectual disability (ID).


MSC-covid-treatment.png

Initial data from early clinical trials show that mesenchymal stem cells could potentially stop the virus, calm the immune response and repair tissue damage caused by COVID-19.

As the pandemic continues, the race is truly on to find an effective treatment for COVID-19. With more than 500 clinical trials currently underway across the world, researchers are channelling all of their efforts and expertise in the hope of finding a cure.